InvestorsHub Logo
Followers 29
Posts 2139
Boards Moderated 0
Alias Born 05/03/2020

Re: None

Friday, 05/21/2021 6:32:51 AM

Friday, May 21, 2021 6:32:51 AM

Post# of 232955
Enjoy: https://emerginggrowth.com/cytodyn-cydy-conference-call-roundup/

"This topline data clearly shows the drop off in benefit on day 21 from not dosing with the drug. This 14 day data is new and has not yet been studied and may meet that EUA test of “may be effective.” So the shorts betting on no EUA in the United States may yet be in for a surprise. There is a lot of publicity surrounding leronlimab that prompted the FDA statement, so the data will be analyzed by the FDA. Independent doctors like Dr Lalezari have taken to the airwaves lobbying for an EUA for critical COVID-19 patients. This interview is excellent as Dr. Lalezari explains why the FDA needs more data and explains the rationale behind the new dosing regimen and how it was a factor in the success of the upcoming trials. "

OH MY.

GLTU/A.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News